Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Revium Rx's Liabilities and Shareholders Equity was $7.11 million in Q2 2026.

Analysis

Revium Rx (RVRC) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Revium Rx came in at $8.3 million, down 59.1% from FY2024.

  • In earlier years, Liabilities and Shareholders Equity was $20.28 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Revium Rx 86.84 Mn 75.21 Mn - 7.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.11 Mn
Mar 31, 2026 7.76 Mn
Dec 31, 2025 8.30 Mn
Dec 31, 2024 20.28 Mn
API Access

Revium Rx Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVRC&period=max&api_key=YOUR_API_KEY